Most infections, different germs don’t spread effectively on flights, says CDC Kumar Jeetendra | May 27, 2020 Most infections and different germs don’t spread effectively on flights, the US Center for Disease Control and Prevention has said in its COVID-19 rules which don’t suggest following social separating between two travelers inside a plane or keeping the center seat vacant. Because of coronavirus pandemic, air traffic inside the US has gone to a …
WHO and different specialists state no proof of COVID-19 losing power Kumar Jeetendra | June 2, 2020 World Health Organization specialists and a scope of different researchers said there was no proof to help a declaration by a prominent Italian specialist that the coronavirus causing the COVID-19 pandemic has been losing strength. Educator Alberto Zangrillo, head of serious consideration at Italy’s San Raffaele Hospital in Lombardy, which endured the worst part of …
Roche’s Tocilizumab neglects to meet essential end focuses for COVID-19 related pneumonia Kumar Jeetendra | July 29, 2020 Swiss Drug maker Roche on July 29 declared that its drug Actemra (Tocilizumab), which has emerged as a widely prescribed drug for treating hosiptalised COVID-19 patients, didn’t fulfill its primary endpoint of improved clinical standing in hospitalised adult patients with acute COVID-19 related pneumonia. In addition, the primary secondary endpoint of decreased patient mortality week …
Johnson and Johnson begins human safety preliminaries Kumar Jeetendra | July 30, 2020 Johnson & Johnson on Thursday kicked off US human safety trials because of its COVID-19 vaccine after releasing details of a research in monkeys that showed its best-performing vaccine candidate offered strong defense in a single dose. When subjected to this virus, six out of six animals who obtained the vaccine candidate proved completely protected …
Moderna looks for full FDA endorsement for its COVID-19 vaccine Kumar Jeetendra | June 1, 2021 American pharmaceutical company Moderna says it has begun the process to win full U.S. regulatory approval for the use of its COVID-19 vaccine in adults. Moderna announced on Tuesday it has begun a “rolling submission” to the Food and Drug Administration of data from its studies of the two-dose vaccine. Moderna’s vaccine already has been …
